Inhibitors |
Cat. No. | Product Name / Activity |
---|---|
5033 | 2-MPPA |
Selective glutamate carboxypeptidase II (GCP II) inhibitor; orally bioavailable | |
1380 | PMPA (NAALADase inhibitor) |
Highly potent, selective NAALADase (GCP II) inhibitor | |
0768 | Riluzole hydrochloride |
Glutamate release inhibitor; also inhibits GABA uptake and blocks NaV channels | |
2675 | ZJ 43 |
Glutamate carboxypeptidase II and III (NAALADase, NAAG peptidase) inhibitor | |
Other |
Cat. No. | Product Name / Activity |
3618 | Acamprosate calcium |
Glutamatergic modulator and GABA agonist | |
0395 | N-Acetylglycyl-D-glutamic acid |
Potent convulsant | |
0341 | L-AP6 |
Selective agonist of the 'quis' effect | |
2538 | L-BMAA hydrochloride |
Neurotoxic amino acid | |
1611 | Lamotrigine |
Inhibits glutamate release. Anticonvulsant | |
2289 | Lamotrigine isethionate |
Inhibits glutamate release. Water-soluble salt of lamotrigine (Cat. No. 1611) | |
1490 | MNI-caged-L-glutamate |
Stable photoreleaser of L-glutamate | |
2687 | Pentylenetetrazole |
CNS stimulant | |
3574 | RuBi-Glutamate |
Caged glutamate; excited by visible wavelengths | |
0636 | Salsolinol-1-carboxylic acid |
Endogenous amino acid | |
0391 | Spaglumic acid |
Putative endogenous neurotransmitter | |
2625 | Zonisamide |
Anticonvulsant, modulates glutamate neurotransmission |